Table 3. Reversible forms of young-onset dementia.
Disorder | Pathogenesis | Clinical Features in addition to Cognitive Dysfunction | Specific Diagnostic Studies with Suggested Order of Testing | Interventions in addition to Supportive Care |
---|---|---|---|---|
Inflammatory | ||||
Multiple sclerosis124,128-132 | Sporadic | Age of onset is 20-40 years; more common in females; may be relapsing/remitting, primary progressive, progressive relapsing, or secondary progressive and present with sensory disturbance of limbs, partial or complete vision loss, motor dysfunction of limbs, diplopia, and ataxia | MRI (enhancing and non-enhancing lesions in brain and/or spinal cord white matter with characteristic perpendicularly oriented “Dawson's fingers” in the periventricular region); CSF (elevated oligoclonal bands and IgG index) | Corticosteroids for acute attack; other immunomodulatory agents for long-term therapy |
Neurosarcoidosis125 | Sporadic | Cranial mononeuropathy (esp CN V, II, VIII), neuroendocrine dysfunction, myelopathy, hydrocephalus, aseptic meningitis, peripheral neuropathy, myopathy, multi-focal neurological deficts | MRI (meningeal or parenchymal enhancement, parenchymal nodules); CSF (elevated opening pressure, normal or low glucose, mononuclear pleocytosis, incr IgG, oligoclonal bands, elevated ACE level); chest CT for lung or lymph node involvement; biopsy for noncaseating granuloma | Corticosteroids for acute symptoms, other immunomodulatory agents for long-term therapy |
Paraneoplastic and Autoimmune Limbic encephalitis126,127,133 | Associated with multiple antibodies +/− occult or known malignancy | Acute/subacute changes in mood and behavior change, complex-partial seizures | MRI (T2 sequence with hyperintensity or contrast enhancement in medial temporal lobes); CSF (elevated protein); EEG (focal or generalized slowing or epileptiform activity in temporal region); paraneoplastic and autoimmune antibody testing on serum +/− CSF | Immunosuppression with high dose corticosteroids acutely, treat underlying tumor, chronic therapy may require long-term immunomodulatory agents |
Infectious | ||||
HIV dementia134,139 | HIV infection with consequent immune activation of microglia | Psychomotor slowing, mood lability | MRI (cerebral atrophy especially in basal ganglia and frontal white matter); blood tests (low CD4 count, high HIV viral load); CSF (rule out other opportunistic causes) | HAART therapy treats HIV infection to reduce dementia risk |
Neurosyphilis135,138,142 | Treponema pallidum | Personality change; meningitis, decr visual acuity, hearing loss, general paresis, tabes dorsalis | MRI (meningeal enhancement), blood tests (VDRL, FTA-ABS); CSF (VDRL, FTA-ABS, incr protein, lymphocyte pleocytosis) | Penicillin G, ceftriaxone if penicillin-allergic, doxycycline if resistant |
Whipple disease136,141,143 | Tropheryma whipplei | Migratory arthralgia, weight loss, GI symptoms, oculomasticatory myorhythmia, ataxia, endocarditis | MRI (variable depending on symptoms); CSF PCR of saliva or stool; upper endoscopy with small bowel biopsy (periodic acid-Schiff-positive macrophages in lamina propria) | Ceftriaxone or penicillin for initial therapy; TMP-SMX as maintenance therapy |
Progressive multifocal leuko-encephalopathy137,140,144,145 | Reactivation of JC virus in immunosuppressed patients | Hemianopia, hemiparesis or monoparesis, ataxia | MRI (multifocal non-enhancing lesions limited to white matter that do not conform to vascular territories without mass effect); CSF (PCR detection of JC virus); EEG (nonspecific diffuse slowing) | HAART and high-dose glocucorticoid therapy if coinfected with HIV; stop immunosuppression; cytarabine for pt with hematologic malignancy; not reversible |
Toxins | ||||
Alcohol and other drugs of abuse (sedatives, inhalants, etc.)146,148 | Ingestion with neurotoxic effects Alcohol-related dementias include thiamine deficiency, hepatic encephalopathy, and Marchiafava-Bignami disease |
All drugs of abuse: ataxia, tremor, blurred vision, dysarthria, psychiatric symptoms, seizures, coma Sedative overdose: respiratory depression Inhalant overdose: respiratory distress, headache, arrhythmia |
All drugs of abuse: urine and serum drug screen Thiamine deficiency: MRI (signal change or atrophy of anterior thalamus or mamillary bodies) Hepatic encephalopathy: MRI (T1 hyperintensity in globus pallidus) Marchiafava-Bignami disease: MRI (signal change in the corpus callosum) Chronic alcohol use: MRI (atrophy in cerebellar vermis> hemispheres) |
Cessation of offending agent Alcohol overdose: IVthiamine before glucose Sedative overdose: flumazenil |
Heavy metal poisoning147 | Occupation/environmental exposures | Mercury poisoning: psychiatric symptoms, distal sensory and motor neuropathy, GI symptoms, weakness, developmental delay, inflammation of gums, constricted visual fields, deafness, ataxia Arsenic poisoning: arrhythmia and ARDS Lead poisoning: anemia |
Mercury poisoning: mercury level in blood >100 mcg/L and urine >100 mcg/L Arsenic poisoning: arsenic level in urine >50 mcg/L Lead poisoning: lead level in blood >25 mcg/dL; NCS |
Avoid exposure; chelation |
Metabolic encephalopathy149-153 | Hepatic encephalopathy: excess ammonia Renal failure or dialysis disequilibrium syndrome: uremia Hyponatremia Hypernatremia |
All: weakness, agitation, fluctuating cognition and behavior, seizures, coma | All: blood tests (comprehensive metabolic panel, ammonia); MRI of brain primarily to exclude other Diagnoses Hepatic encephalopathy: MRI (T1 hyperintensity in globus pallidus) |
All: treat underlying cause Hepatic encephalopathy: lactulose and rifaximin Uremia: dialysis Hyponatremia: correct slowly with IVF to avoid central pontine myelinolysis |
Wilson's disease172-174 | AR mutation in ATP7B on Chr13 inhibits copper metabolism | Psychiatric symptoms, liver disease, movement disorder or rigid dystonia, ataxia, Kayser-Fleischer rings on slit-lamp exam | Blood tests (low copper and ceruloplasmin); urine (increased copper excretion); liver biopsy (incr hepatic copper concentration); genetic testing | Penicillamine, trientine, zinc |
Endocrinopathy | ||||
Glucose dysregulation (hypoglycemia, hyperglycemia)154 | Hypoglycemia: insulin, alcohol, malnourishment, liver disease Hyperglycemia: diabetes esp type I with inadequate insulin or acute infection |
Hypoglycemia: change in behavior with anxiety, visual changes, seizures, palpitations, diaphoresis, variable focal neurological deficits, perioral paresthesia around mouth Hyperglycemia: polyuria, polydipsia, GI symptoms, weakness, fatigue, shortness of breath, fruity breath |
Hypoglycemia: blood tests (glucose <60 mg/dL, assess for associated metabolic derangements) Hyperglycemia: blood tests (glucose >200 mg/dL, assess for associated metabolic derangements) |
Hypoglycemia: carbohydrates (15-20g oral glucose), glucagon injection, IV dextrose Hyperglycemia: IVF, insulin |
Thyroid dysfunction (hypothyroidism, hyperthyroidism)155,156,161,164,167 | Hypothyroidism: autoimmune thyroiditis, infiltrative disease, TSH orTRH deficiency Hyperthyroidism: Graves disease, multinodular goiter |
Hypothyroidism: weakness, fatigue, cold intolerance, constipation, dry skin, weight gain, hoarseness, bradycardia, depression Hyperthyroidism: heat intolerance, anxiety/irritability, tremor, diaphoresis, diarrhea, weight loss, tachycardia, Graves ophthalmopathy |
Blood tests for both (TSH, free T4, thyroid autoantibodies); MRI (to rule out other possibilities); thyroid ultrasound Hypothyroidism: EEG (slow background activity) Hyperthyroidism: EEG (epileptiform activity) |
Hypothyroidism: levothyroxine Hyperthyroidism: radioactive iodine, antithyroid medications, beta blocker, or thyroidectomy |
Parathyroid dysfunction (hypoparathyroidism, hyperparathyroidism)157,158,162,163 | Hypoparathyroidism: radiation of head/neck, radioactive iodine, low calcium intake Hyperparathyroidism: parathyroid adenoma or hyperplasia, parathyroid carcinoma, ectopic PTH from non-parathyroid neoplasm, multiple genetic mutations |
Hypoparathyroidism: weakness, fatigue, irritability/anxiety/depression, tetany, seizures, muscle cramps, papilledema, extrapyramidal symptoms Hyperparathyroidism: weakness, fatigue, bone pain, myalgia, depression, nephrolithiasis, osteoporosis |
Blood tests for both (Ca, PTH, Phosphorus, Mg, creatinine, vitamin D, alkaline phosphatase); urinary calcium Hypoparathyroidism: CT (basal ganglia calcification) Hyperparathyroidism: bone mineral density, renal imaging |
Hypoparathyroidism: calcium and vitamin D Hyperparathyroidism: avoid calcium in diet, saline hydration, calcitonin, bisphosphonates, glucocorticoids, dialysis |
Addison's disease159,165,168 | Primary adrenal insufficiency, autoimmune/infectious adrenalitis, metastatic cancer or lymphoma, adrenal hemorrhage or infarction, abrupt withdrawal from corticosteroids | GI symptoms, weakness, fatigue, lethargy, fever, systemic “shock” and coma, hyperpigmentation if primary adrenal insufficiency | Blood tests: 8 AM serum cortisol and plasma ACTH; ACTH stimulation test; basal ACTH, renin, aldosterone levels | IVF resuscitation, glucocorticoids (hydrocortisone, dexamethasone, prednisone, fludrocortisone), DHEA if glucocorticoids fail |
Cushing's syndrome159,160,166 | Cushing's disease (pituitary hypersecretion of ACTH), ectopic secretion of ACTH by nonpituitary tumors, ectopic secretion of CRH, adrenal adenoma or hyperplasia, exogenous glucocorticoids | Central obesity, moon facies, supraclavicular fat pads, skin atrophy, purple striae, proximal muscle weakness, hirsutism, oligomenorrhea, impotence, obesity, hypertension, glucose intolerance | Late night salivary cortisol, urinary cortisol, low dose dexamethasone suppression test (2 of these must be abnormal); CT or MRI of adrenal glands or pituitary gland | Resection of ACTH- or cortisol-secreting tumor; pituitary irradiation; bilateral adrenalectomy; somatostatin analog for metastatic or ectopic ACTH-secreting tumor |
Nutritional deficiency | ||||
B12169,171 | pernicious anemia, gastrectomy/gastritis, strict vegans | megaloblastic anemia, jaundice, fatigue, atrophic glossitis, subacute combined degeneration (sensory and motor findings referable to spinal cord tracts), peripheral polyneuropathy | blood test (low B12 and folate, high homocysteine and methylmalonic acid, Ab to intrinsic factor); peripheral blood smear (macrocytic RBC, hypersegmented neutrophils); Schilling test; EMG and NCS; MRI spine (T2 hyperintensity of dorsal columns) | intramuscular B12 (1 mg every day for 1 week, then 1 mg every week for 4 weeks, then 1 mg every month until deficiency is reversed) |
Thiamine (associated with Wernicke-Korsakoff syndrome)146 | Malnourishment associated with chronic alcoholism, hyperemesis | Prominent anterograde memory deficits with confabulation, ataxia, ophthalmoplegia | Blood test (thiamine, RBC folate); MRI (signal abnormality or atrophy of medial thalamus, mamillary bodies, periaqueductal gray matter) | IV thiamine before glucose |
Niacin (pellagra)170 | Malnutrition associated with alcoholism or anorexia, carcinoid syndrome, prolonged use of isoniazid, Hartnup disease (defective amino acid transporter) | Dermatitis, diarrhea | Bloodwork (low niacin, tryptophan, NAD, NADP) | Niacin supplementation (25-300 mg by mouth daily) |
Transient epileptic amnesia175 | Unknown | More common in elderly; recurrent transient episodes of isolated anterograde memory loss, interictal memory difficulties | EEG (temporal lobe spikes); CT or MRI (atrophy of hippocampus) | Anticonvulsant therapy affects progression but does not completely reverse cognitive deficits |
Obstructive sleep apnea176,178 | Intermittent hypoxemia or sleep deprivation; Risk factors include obesity, large neck circumference, anatomically narrow airway | Snoring, snort arousals, morning headache, daytime somnolence, irregular respiratory patterns during sleep | Polysomnography with apneic pauses | Behavior modification (weight loss, change sleep position), positive airway pressure, oral devices, uvular and palatal surgery |
Normal pressure hydrocephalus179 | Impaired CSF flow; more common after head trauma, CNS infection, CNS hemorrhage | Gait disturbance (“magnetic”), urinary incontinence | MRI (ventriculomegaly, periventricular white matter hyperintensity, no evidence of CSF flow obstruction); high volume LP or CSF drain to identify patients that may respond to shunt placement | Ventriculoperitoneal shunt; cognitive deficits rarely reverse with this procedure although intervention may prevent further decline |
Abbreviations: CSF = cerebrospinal fluid
LP = lumbar puncture
MRI = magnetic resonance imaging
EMG = electromyography
NCS = nerve conduction study
EEG = electroencephalography
PET = positron emission tomography
CT = computed tomography
EKG = electrocardiography
ACE = angiotensin converting enzyme
HIV = human immunodeficiency virus
HAART = highly active antiretroviral therapy
VDRL = venereal disease research laboratory
FTA-ABS = fluorescent treponemal antibody-absorption
PCR = polymerase chain reaction
ARDS = adult respiratory distress syndrome
IVF = intravenous fluids
TSH = thyroid-stimulating hormone
TRH = thyrotropin-releasing hormone
T4 = thyroxine
T3 = triiodothyronine
PTH = parathyroid hormone
ACTH = adrenocorticotropic hormone
DHEA = dehydroepiandrosterone
CRH = corticotropin-releasing hormone
Ab = antibody
NAD = nicotinamide adenine dinucleotide
NADP = nicotinamide adenine dinucleotide phosphate